3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum.
3M’s $8.4bn health care division will be spun out from the company in the first half of 2024 under plans announced this week. The new entity will be known as Solventum, a portmanteau of “solving” and “momentum.”
The company originally expected to complete the tax-free transaction by year-end 2023. (Also see "3M Plans To Spin Off...
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.
